DE60120187D1 - Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen - Google Patents

Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen

Info

Publication number
DE60120187D1
DE60120187D1 DE60120187T DE60120187T DE60120187D1 DE 60120187 D1 DE60120187 D1 DE 60120187D1 DE 60120187 T DE60120187 T DE 60120187T DE 60120187 T DE60120187 T DE 60120187T DE 60120187 D1 DE60120187 D1 DE 60120187D1
Authority
DE
Germany
Prior art keywords
diagnostic
shorten
therapeutic applications
bard1 protein
bard1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60120187T
Other languages
English (en)
Other versions
DE60120187T2 (de
Inventor
Fabien Gautier
Jean Harb
Khaled Meflah
Irmgard Irminger-Finger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Irminger-Finger Irmigard Genf/geneva Ch
Original Assignee
Universite de Geneve
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Geneve, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Universite de Geneve
Publication of DE60120187D1 publication Critical patent/DE60120187D1/de
Application granted granted Critical
Publication of DE60120187T2 publication Critical patent/DE60120187T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60120187T 2000-09-01 2001-09-03 Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen Expired - Lifetime DE60120187T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0011207 2000-09-01
FR0011207A FR2813606B1 (fr) 2000-09-01 2000-09-01 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
PCT/FR2001/002731 WO2002018536A2 (fr) 2000-09-01 2001-09-03 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques

Publications (2)

Publication Number Publication Date
DE60120187D1 true DE60120187D1 (de) 2006-07-06
DE60120187T2 DE60120187T2 (de) 2007-03-29

Family

ID=8853916

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60120187T Expired - Lifetime DE60120187T2 (de) 2000-09-01 2001-09-03 Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen

Country Status (8)

Country Link
US (2) US7566764B2 (de)
EP (1) EP1313855B1 (de)
JP (1) JP4995399B2 (de)
AT (1) ATE328082T1 (de)
CA (1) CA2421258C (de)
DE (1) DE60120187T2 (de)
FR (1) FR2813606B1 (de)
WO (1) WO2002018536A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100130590A1 (en) * 2007-04-02 2010-05-27 Hopitaux Universitaires De Geneve Deletion bearing bard1 isoforms and use thereof
BR112013003506B1 (pt) * 2010-08-17 2022-02-08 Universite De Geneve Método para detectar a presença de uma isoforma de bard1 e método para discriminar câncer
EP3063543B1 (de) 2013-10-31 2020-03-11 Regeneron Pharmaceuticals, Inc. Kompetitiver liganden-bindungstest zum nachweis von neutralisierenden antikörpern
EP2871480A1 (de) * 2013-11-06 2015-05-13 Bard1Ag SA Lungenkrebsdiagnose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4586697A (en) * 1996-09-20 1998-04-14 Board Of Regents, The University Of Texas System Compositions and methods comprising bard1 and other brca1 binding proteins
US6416758B1 (en) * 1999-04-28 2002-07-09 Board Of Regents, The University Of Texax System Antibody conjugate kits for selectively inhibiting VEGF

Also Published As

Publication number Publication date
CA2421258C (fr) 2011-04-19
US20040234959A1 (en) 2004-11-25
EP1313855A2 (de) 2003-05-28
US7566764B2 (en) 2009-07-28
FR2813606A1 (fr) 2002-03-08
WO2002018536A3 (fr) 2003-01-03
JP4995399B2 (ja) 2012-08-08
CA2421258A1 (fr) 2002-03-07
JP2004518410A (ja) 2004-06-24
US20100016228A1 (en) 2010-01-21
ATE328082T1 (de) 2006-06-15
FR2813606B1 (fr) 2004-04-30
EP1313855B1 (de) 2006-05-31
DE60120187T2 (de) 2007-03-29
WO2002018536A2 (fr) 2002-03-07

Similar Documents

Publication Publication Date Title
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
MXPA03010079A (es) Formulaciones de oxicodona de administracion una vez al dia.
MY150237A (en) Cripto blocking antibodies and uses thereof
BR9908823A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
HK1080517A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
DE69839444D1 (de) Smad 6 und dessen anwendungen
ATE462006T1 (de) Isoform des vegfs
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
DE60027295D1 (de) Sphingosinekinase
GB0100551D0 (en) Protein
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
DE60233532D1 (de) An proteinphosphatase 2a bindende synthetische ode anwendungen
AUPP472398A0 (en) Protease susceptibility II
EP1071443A4 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
WO2002077241A3 (en) Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
PL374550A1 (en) Il-17 like molecules and uses thereof
HUP0402327A2 (hu) Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2003093305A3 (en) Teneurin c-terminal associated peptides (tcap) and uses thereof
FR2804127B1 (fr) Gene srn1 implique dans le syndrome nephrotique cortico- resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: IRMINGER-FINGER, IRMIGARD, GENF/GENEVA, CH

8364 No opposition during term of opposition